search
Back to results

Post-Operative Constipation Following Total Knee Arthroplasty

Primary Purpose

Constipation

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Propylene Glycol
Docusate Sodium
Sponsored by
The Cleveland Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Constipation focused on measuring constipation, postoperative, total knee arthroplasty

Eligibility Criteria

20 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Admission to Cleveland Clinic Lutheran Hospital surgical unit 5D
  • Single total knee replacement surgery by orthopedic surgeons Stearns, Murray, or Molloy
  • Age greater than 20
  • Discharge to home on postoperative day one

Exclusion Criteria:

  • Known allergy to PEG 3350
  • Unable to complete a follow up phone call in English
  • Known renal disease, irritable bowel syndrome, or inflammatory bowel disease (Crohn's disease or ulcerative colitis)

Sites / Locations

  • Cleveland Clinic Lutheran Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Drug: Docusate Sodium

Drug: Propylene Glycol

Arm Description

Docusate sodium one pill to be taken twice a day by mouth for 28 days

One standard dose (17 grams) of propylene glycol by mouth on postoperative day one

Outcomes

Primary Outcome Measures

Bowel Movement (BM) Within 3 Days of Surgery
Number of people who report normal bowel movement in the first three postoperative days following single total knee joint replacement

Secondary Outcome Measures

Straining With BM
For patients who had a BM within 3 days: rated 0 no straining to 10 worst straining imaginable; 3 categories developed: 0 = score of 0; 1 = score of 1-5 and 2 = score of 6-10
Pain With BM
For patients who had a BM within 3 days: rated 0 no pain to 10 worst pain imaginable; 3 categories developed: 0 = score of 0; 1 = score of 1-5 and 2 = score of 6-10

Full Information

First Posted
May 5, 2020
Last Updated
January 18, 2022
Sponsor
The Cleveland Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT04380090
Brief Title
Post-Operative Constipation Following Total Knee Arthroplasty
Official Title
Efficacy of One Dose of Laxative on Post-Operative Constipation Following Total Knee Arthroplasty
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
February 21, 2020 (Actual)
Primary Completion Date
July 15, 2020 (Actual)
Study Completion Date
July 15, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Postoperative constipation, defined as no fully satisfying bowel movement within the first three postoperative days, is a common occurrence with some researchers estimating that between 41 and 85% of postoperative patients experience symptoms. Causes include intraoperative medications, postoperative opioid analgesics, decreased mobility, and decreased oral intake. Constipation significantly impacts quality of life following surgery. Current standard of care for preventing postoperative constipation for patients having a single total knee arthroplasty at Cleveland Clinic is discharge on postoperative day one with either a prescription to be filled for docusate sodium (brand name Colace®) 100 mg to be taken two times a day by mouth for twenty eight days or the filled prescription, plus discharge instructions on ways to avoid and treat constipation. Research results show that docusate sodium is ineffective for preventing postoperative constipation in orthopedic surgery patients, and anecdotal reports confirm this finding. The proposed study uses a 2-group non-equivalent cohort design to evaluate the effect of one standard dose (17 grams) of an over-the-counter osmotic laxative (propylene glycol (PEG 3350), brand name Miralax) by mouth prior to discharge to the current standard of care. The primary outcome measure is whether patients report of a fully satisfying, normal for them, bowel movement within the first three postoperative days. Patient reported data will be collected by phone call four to seven days following surgery. Pertinent patient characteristics will be abstracted from the electronic medical record. The sample will consist of patients over twenty years old having a single total knee arthroplasty by Drs. Stearns, Molloy, or Murray who are admitted to unit 5D at Cleveland Clinic Lutheran Hospital postoperatively. Intent to treat analysis will be performed using logistic and linear regression models, adjusting for differences between groups on patient and surgical characteristics. Based on use of a two-sided Pearson chi-square test with 80% power and significance level of 0.05, 49 patients per group are required to detect a 25% decrease in constipation rate. To account for attrition we will over sample by 50% for a total of 74 per group or 148 total participants.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Constipation
Keywords
constipation, postoperative, total knee arthroplasty

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
154 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Drug: Docusate Sodium
Arm Type
Active Comparator
Arm Description
Docusate sodium one pill to be taken twice a day by mouth for 28 days
Arm Title
Drug: Propylene Glycol
Arm Type
Experimental
Arm Description
One standard dose (17 grams) of propylene glycol by mouth on postoperative day one
Intervention Type
Drug
Intervention Name(s)
Propylene Glycol
Other Intervention Name(s)
Miralax, PEG 3350
Intervention Description
Patients in the propylene glycol arm will receive one standard dose of the drug on postoperative day one prior to discharge with the aim of decreasing rates of postoperative constipation for patients following single total knee replacement surgery
Intervention Type
Drug
Intervention Name(s)
Docusate Sodium
Other Intervention Name(s)
Colace
Intervention Description
Patients in the docusate sodium arm are receiving the current standard of care for prevention of postoperative constipation following single total knee replacement surgery, docusate sodium one pill twice a day by mouth for 28 days
Primary Outcome Measure Information:
Title
Bowel Movement (BM) Within 3 Days of Surgery
Description
Number of people who report normal bowel movement in the first three postoperative days following single total knee joint replacement
Time Frame
3 days postoperative
Secondary Outcome Measure Information:
Title
Straining With BM
Description
For patients who had a BM within 3 days: rated 0 no straining to 10 worst straining imaginable; 3 categories developed: 0 = score of 0; 1 = score of 1-5 and 2 = score of 6-10
Time Frame
3 days postoperative
Title
Pain With BM
Description
For patients who had a BM within 3 days: rated 0 no pain to 10 worst pain imaginable; 3 categories developed: 0 = score of 0; 1 = score of 1-5 and 2 = score of 6-10
Time Frame
3 days postoperative
Other Pre-specified Outcome Measures:
Title
Laxative Use Within 3 Days of Surgery
Description
Participant response to question: Did you take any laxatives to help you have a bowel movement in those first three days after your surgery?(yes/no) Rate of laxative use in the postoperative period was calculated for sensitivity analyses and possible adjustment of statistical models based on any group differences.
Time Frame
3 days postoperative
Title
Opioid Use Within 3 Days of Surgery
Description
Participant response to question: In the first three days following your surgery, did you take any of the opioid pain medicine prescribed by your surgeon?(yes/no) Rate of opioid use in the postoperative period was calculated for sensitivity analyses and possible adjustment of statistical models based on any group differences.
Time Frame
3 days postoperative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Admission to Cleveland Clinic Lutheran Hospital surgical unit 5D Single total knee replacement surgery by orthopedic surgeons Stearns, Murray, or Molloy Age greater than 20 Discharge to home on postoperative day one Exclusion Criteria: Known allergy to PEG 3350 Unable to complete a follow up phone call in English Known renal disease, irritable bowel syndrome, or inflammatory bowel disease (Crohn's disease or ulcerative colitis)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kathleen Gonzalez, RN, MSN
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic Lutheran Hospital
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44113
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Post-Operative Constipation Following Total Knee Arthroplasty

We'll reach out to this number within 24 hrs